Trump: Iranian ships nearing blockade will be destroyed

 US President Donald Trump took to Truth Social on Monday to confirm his country has begun blocking ships from entering or exiting Iranian ports, while threatening the Islamic Republic that if any of their "fast attack ships" approach the blockade, they will be "immediately ELIMINATED."

"If any of the Iranian ships come anywhere close to our BLOCKADE, they will be immediately ELIMINATED, using the same system of kill that we use against the drug dealers on boats at Sea. It is quick and brutal," he wrote.

US CENTCOM previously said the blockade would be implemented impartially, targeting ships of all nations entering or departing Iranian ports and coastal areas, including those located along the Arabian Gulf and the Gulf of Oman.

https://breakingthenews.net/Article/Trump:-Iranian-ships-nearing-blockade-will-be-destroyed/66057036

Amazon.com Inc. (AMZN) Proposes Settlement in Driver Employment Case

 On April 13, 2026, the federal government is negotiating a settlement regarding Amazon.com Inc.'s AMZN -0.62% treatment of delivery drivers, potentially avoiding a significant ruling on its employment status. The National Labor Relations Board (NLRB) has been pursuing Amazon since 2024 for allegedly violating drivers' rights linked to a former contractor in California. The NLRB claimed Amazon acted as a "joint employer," which would require it to engage in union negotiations. While Amazon has denied wrongdoing, a proposed settlement would offer two weeks' pay to up to 84 affected workers without admitting liability. This resolution could significantly impact ongoing legal proceedings.

https://www.gurufocus.com/news/8789243/amazoncom-inc-amzn-proposes-settlement-in-driver-employment-case

ImageneBio announces $30 million private placement

 

ImageneBio announces $30 million private placement of pre-funded warrants with institutional investors to fund IMG-007 development

• Proceeds will support ongoing development of lead drug candidate IMG-007 for atopic dermatitis and alopecia areata.

https://finviz.com/quote.ashx?t=IMA&p=d

CVRx sees preliminary Q1 2026 revenue of $14.7–$14.8 million, about 20% higher year over year

 

• Company reports first site activation in its BENEFIT-HF trial.

https://finviz.com/quote.ashx?t=CVRX&p=d

AdaptHealth closes $1.1B senior secured credit facility, extends debt to 2031

 

 lowers borrowing costs, increases revolver capacity

• 2026 guidance remains unchanged following the new $1.1 billion senior secured credit facility.

https://finviz.com/quote.ashx?t=AHCO&p=d

Regeneron, Telix Pharmaceuticals to co-develop radiopharmaceutical cancer therapies

 

 in 50/50 collaboration with $40M upfront, up to $2.1B milestones plus royalties

• Collaboration uses a 50/50 cost and profit-sharing model between Regeneron and Telix Pharmaceuticals.
• Approval expands Dupixent’s EU label for chronic spontaneous urticaria to children aged 2 to 11.

https://finviz.com/quote.ashx?t=REGN&p=d

Stryker enters definitive agreement to acquire Amplitude Vascular Systems

adding next-generation intravascular lithotripsy platform to peripheral vascular portfolio

https://finviz.com/quote.ashx?t=SYK&p=d